Seed · Healthtech · Sintra, Portugal · Founded 2022 · 11–50 employees
Clarrio.ai, formerly known as Knowlepsy, develops an AI-driven, device-agnostic health platform designed to manage chronic diseases with an initial focus on epilepsy. By aggregating fragmented data from over 300 connected wearables, IoT devices, electronic health records, and patient check-ins, the company generates predictive risk scores to foresee health crises like seizures. In November 2025, the startup announced a seed funding round following its integration into the Launch Africa Ventures' Fund II portfolio. Clarrio.ai has also expanded its ecosystem by participating in prominent accelerator programs, including Startup Lisboa, Unicorn Factory Lisboa, and the TASMU Accelerator in Qatar.
No open roles listed right now.